Validation of haematology peripheral blood slide review rules at various tiers of diagnostic laboratories in South Africa by Bouwer, Nikki
VALIDATION OF HAEMATOLOGY 
PERIPHERAL BLOOD SLIDE REVIEW RULES 
AT VARIOUS TIERS OF DIAGNOSTIC 
LABORATORIES IN SOUTH AFRICA 
Dr Nikki Bouwer 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Research report submitted to the Faculty of Health Sciences, University of the Witwatersrand, 
Johannesburg, in partial fulfilment of the requirements for degree of Master of Medicine in the branch of 
Haematology. 
Johannesburg, 2017
i 
 
DECLARATION 
I, Nikki Bouwer, declare that this research report is my own, unaided work. It is being submitted 
for the degree of Master of Medicine in the branch of Haematology in the University of the 
Witwatersrand, Johannesburg. It has not been submitted before for any degree or examination at 
this or any other University.  
 
.......................................... 
N. Bouwer 
............ Day of ...............................2017. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ii 
 
DEDICATION 
This research report is dedicated to my family for their endless support during this journey and to 
all the staff working in the regional and district laboratories across South Africa facing increasing 
pressure in the workplace, may this study be one of many to lessen the load. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
iii 
 
ABSTRACT 
Automated analysers in the haematology laboratory have vastly improved since their inception in 
the mid-20th Century. The capability of these analysers to provide information exceeding a 
numerical output have made them allies in the clinical laboratory field. These analysers generate 
suspect flags and additional differential parameters with enhanced sensitivity and specificity 
which can assist in reducing manual peripheral blood smear (PBS) review rates and increasing 
laboratory productivity.  In 2005, the staffing pressures faced by clinical laboratories prompted 
the International Consensus Group (ICGH) for Haematology Review to establish a set of criteria 
(consensus rules) to guide manual smear review of automated full blood counts (FBC) and white 
blood cell differential counts (Diff) in order to reduce unnecessary smear review rates. The 
usefulness of these rules is dependent on the patient population, laboratory criteria for PBS 
review and the specifications of the analyser.  
The aim of this study was to apply ICGH rules to FBC samples (with and without Diffs) from 
tertiary, regional and district diagnostic laboratory tiers, to evaluate their efficiency, and to 
optimise their performance in the South African context.  
In this study, the ICGH rules were compared to the individual representative laboratory standard 
operating procedures (SOP) for smear review in 600 samples from laboratories representing the 
tertiary, regional and district health tiers. Manual PBS review was the reference method. The 
rules were analysed for sensitivity, specificity and efficiency. False negative (FN) and false 
positive (FP) rates were also recorded for the rule set collectively, as well as for individual 
parameter and morphology flags.  In order to optimise the ICGH rules for our setting, samples 
with FP flagging were then more closely analysed to determine if exclusion or modification of the 
flags triggered in these samples would be beneficial. 
Smear review rates were substantially reduced on implementation of the ICGH rules in the 
tertiary laboratory as compared to the current laboratory SOP (82% vs 70%; p=0.022), were not 
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significantly altered in the regional laboratory (72% vs 80%; p = 0.198), while review rates 
increased on implementation of the rules in the district laboratory (67.1% vs 79.3%; p <0.0001).  
FN rates were reduced in all three sites, with the greatest reduction occurring in the district 
laboratory (dropping from 32% to 5%; p < 0.0001). Efficiency rates of the rule set were similar to 
those reported in the literature in the tertiary laboratory (78.1%), but were poorer in the regional 
(74.5%) and district laboratories (68.6%). Leukopenia and thrombocytopenia were the most 
common parameter flags triggered in the tertiary hospital (20.7% and 25% of samples 
respectively), while anaemia and microcytosis were most prevalent in the regional facility (22.5% 
and 17.5% of samples respectively). The most common abnormal parameter in the district 
laboratory was leucopenia (WCC<4 x 109/L) (16.4%). The analysers from the different tiers 
triggered morphology flags variably.  
The findings of this study indicate the need for optimisation of the rules. Recommendations were 
made for each tier individually, each of which could reduce smear review rates further without 
increasing the clinically significant FN rates. In the tertiary laboratory, request for a Diff alone 
should not be a criterion for smear review and the white cell threshold for smear review should be 
reduced from 4 x 109/L to 2 x 109/L. Recommendations for the regional laboratory include 
modification of the WCC threshold to that of <2 x 109/L and exclusion of the platelet clumping 
(PCL) rule when the platelet count is normal/increased. In the district laboratory the nucleated red 
blood cell (NRBC) flag and PCL flag in samples with normal/high platelet counts should be 
excluded.  
Conclusion: 
Implementation of optimised ICGH rules would be beneficial to all laboratory tiers in South 
Africa, most particularly in the tertiary laboratory setting.   
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1. Background and rationale  
1.1  History of the Full Blood Count 
1.1.1 Manual Cell Counting and the Beginning of Automation 
The interest in the inspection of blood in diagnostics dates back to ancient times where a very 
basic analysis included colour and structure of blood. A more detailed blood cell analysis became 
possible with the invention of the microscope more than 300 years ago and in 1852 the 
physiologist Karl Vierordt described the first counting method allowing for the quantitative 
analysis of the separate blood components (1, 2). In the late 1800’s George Oliver proposed a 
new method of cell counting which was based on the visual perception of light loss due to 
absorption or scattering in a tube of diluted blood (3, 4).  This method was improved by the 
addition of photodetectors with Mercandier et al  showing in 1926 that a blood count could be 
derived if the photometer was adequately calibrated (4). In 1934 Moldavan proposed a method of 
counting cells as they flowed through a capillary tube on a microscope while in suspension (5). 
This method inspired Wallace and Joseph Coulter to introduce the world to the first non-optical 
cell counter at the National Electronics Conference in Chicago in 1956 (6, 7). This is referred to 
as the Coulter method. 
1.2 Modern Analytical Principles 
The principle of the Coulter method is also known as the “Electrical Sensing Zone” method (8).  
This method uses two electrodes, one placed in a tube with an aperture of a known size and the 
other in a low concentration electrolyte solution containing the particles of interest. An electrical 
field is applied creating an electrical current path. The impedance between the two electrodes is 
measured. As the particles pass through the aperture, the impedance changes and this is measured 
as a voltage pulse. The pulse height is proportional to the volume of electrolyte displaced. Cells 
are counted and sizes determined (7). The discovery of the Coulter principle for cell counting was 
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just the start for automated analysers in haematology as further improvements were on the 
horizon.  
Later multi-parameter analysers capable of analysis by several methods such as optical, 
impedance and turbidimetry were developed. This allowed for improved precision, higher 
throughput and shorter turnaround time. A defining event in the transition from manual to 
automated cell counting came with the advent and improvement of high-throughput flow 
cytometry. This occurred in the 1960’s and was refined in the 1970’s to include fluorescence-
based cell sorting (4, 9). Current haematology analysers make use of the following principles: 
Impedance (as is explained by the coulter principle), high frequency measurement, light scatter 
from different angles, fluorescence flow cytometry and spectrophotometry. 
High frequency measurement is used predominantly to separate immature granulocytes from 
mature cells and usually occurs after red cell lysis. Impedance measurement and exposure to a 
high frequency current occur simultaneously. The result of this concurrent measurement and 
exposure determine the internal complexity of the cell therefore allowing for differentiation of 
cells (2, 10) 
Light scatter measured at different angles is a method of measurement requiring a monochromatic 
light source (laser diode with a specific wavelength) which allows measurement of red blood cells 
(RBC), platelets (PLTS) and white blood cells (WBC). The light scatter is measured at different 
angles (11).  Three main distribution curves are generated from the light scatter pattern of red 
cells and platelets including: mean cell volume (MCV) of RBC, mean platelet volume (MPV) and 
haemoglobin (HB) concentration (2).  
Cytophotometry resulting in the measurement of cells using fluorescent labels attached to either 
membrane or cytoplasmic markers is now more commonly used in the immunological 
differentiation of WBC and cell counting for example differentiating B and T lymphocytes. The 
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principle is similar to that of scattered light except that fluorescent labelled cells are detected and 
the data processed to allow a visual representation of the different cells(12). In most instruments 
data is displayed as either histograms (usually for red cell, platelet and white cell relative 
numbers) or scatterplots (usually  for identification of white cell subpopulations)(10). 
Today modern analysers have a throughput of up to approximately 1000 full blood count analyses 
per hour. 
These improvements allowed automation in the laboratory to play a more significant role, 
increasing accuracy, efficiency and productivity.  
1.2.1 Analysers in the National Health Laboratory Service 
The National Health Laboratory Services (NHLS) is the largest laboratory service provider in 
South Africa. The commonest analysers in use in the NHLS are the Siemens Advia 2120 
(Siemens Healthcare Diagnostics, NY, USA), Sysmex family of analysers (XT2000i, XE, XN 
and XS) (Sysmex corporation, Kobe, Japan), and the Beckman Coulter range (Beckman Coulter, 
Inc, Brea, California, USA). The analytical principles of these instruments and the morphology 
flags generated by each of them are summarised in Table 1.1. Specifications of the different 
analysers are presented in Appendix A Table A.1. 
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Table 1.1 Analyser Principles 
Analyser Parameter Principle 
Advia 2120 (Siemens Healthcare 
Diagnostics, NY, USA) 
Parameter Principle 
 Red cell count 
 
Haemoglobin 
 
Platelet count 
 
 
White cell count & differential count: 
Isovolumetric sphering 
Light scatter analysis 
Red cell lysis 
Colorimetric optical analysis 
Isovolumetric sphering 
Light scatter analysis (amplified 12-30x) 
BASO chamber:  
Red cells, platelets lysed 
Light scatter 
PEROX chamber: 
Red cells, platelets lysed  
White cell shrinkage 
Light scatter 
Peroxidase staining 
 Morphology Flags  
 Large platelets 
 
Platelet clumping 
Red cell fragments 
Nucleated red blood cells (NRBCs) 
 
Immature granulocytes (IG) 
 
 
Blasts 
Atypical lymphocytes 
Refractive index between 1.35 & 1.40 
Cell volume between 20fl and 60fl 
“Noise” area on PEROX cytogram 
Cell volume <30 but refractive index >1.40. 
Recognised on the BASO & PEROX channels 
according to size and nuclear density. 
Large cells with high peroxidase activity. Seen 
in the neutrophil area of the PEROX cytogram 
and mononuclear area of the BASO cytogram. 
Blast cluster of the BASO cytogram. 
LUC region on PEROX cytogram. 
Sysmex analysers 
(Sysmex corporation, Kobe, Japan) 
Parameter  
 Red cell count 
Haemoglobin 
 
Platelets 
 
White cell count & differential count 
Hydrodynamic focusing and Impedance 
Red cell lysis 
Spectrophotometry 
Impedance 
Optical fluorescence 
Light scatter 
Fluorescence 
 Morphology  Flags  
 
 
Immature granulocytes 
Blasts 
Left shift 
Atypical Lymphocytes 
NRBC 
 
Lysis resistant RBC 
 
 
RBC agglutination 
Turbidity/HGB interference 
 
Iron deficiency 
Fragments 
 
Platelet clumps 
 
 
IG cluster on the diff scattergram. 
Blast cluster on diff scattergram. 
Left shift cluster on diff scattergram. 
ALYM cluster on diff scattergram 
? NRBC generated when clustered in NRBC 
region on diff scattergram. 
Abnormal clustering in RBC ghost population 
region 
Calculated from RBC histogram. 
MCHC> 36.5g/dL 
Calculation and size comparison of 
MCV,MCHC,RDW 
Determined from reticulocyte scattergram 
Clustering in right upper ghost regions in DIFF 
or NRBC scattergrams. 
Read from the PEROX scattergram. Not 
included in the diff count but recorded for 
flagging.  
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Table 1.1 continued 
Analyser Parameter Principle 
Beckman Coulter Act5Diff 
(Beckman Coulter, Inc, Brea, 
California, USA) 
Parameter  
 
Red cell count 
Haemoglobin 
Platelets 
 
White cell count/basophil count. 
Five part differential count 
Coulter principle 
Spectrophotometry 
Coulter principle – differentiated from red 
cells according to size. 
Coulter principle & differential lysis. 
Flow impedance &cytochemical staining 
 Morphology Flags  
 
Large Immature cells  
 
Blasts 
 
 
Small lymphocyte (SL) 
 
 
Left shift 
 
 
 
Cold agglutinin 
Schistocyte 
Platelet aggregates 
 
 
NRBC 
Larger volume and increased intensity of 
scattered light (if IMM reading is increased) 
Larger than monocytes but similar 
absorbance. Some may be located between 
normal lymphocyte and monocyte 
populations. 
Suspected abnormalities include small 
lymphocytes, platelet aggregates, NRBCs 
and lysis-resistant RBCs. 
If increased number of cells in 
monocyte/neutrophils and 
neutrophil/lymphocyte gate on diff plot. 
 
MCHC value high 
Derived from the platelet histogram 
Debris flag with low platelet count or debris 
with mean platelet volume >10 or debris with 
platelet distribution width >20. 
If number of particles counted in the SL 
(small lymphocyte) or SL1 region of the diff 
plot of the analyser exceeds the set limit and 
the two WBC counts performed by the 
anlyser on the sample differ by more than the 
predetermined limit (i.e.WBC vote out) then 
this flag is triggered.  
 
1.3 Instrument generated flags 
Analysers use a range of techniques to detect abnormalities in the blood, be it quantitative (i.e. 
reflecting derangements of 1/more full blood count (FBC) parameter/s) or through the use of 
morphology flags. The latter vary somewhat between analysers, as their generation depends on 
the technology employed by the instrument in question. However, there are several morphology 
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flags which are common to most haematology analysers, including those querying the presence of 
platelet clumping (PCL), atypical lymphocytes (ALYM), blasts and immature granulocytes (IG). 
The instrument flags generated by the analysers commonly used in the NHLS are summarised in 
Table 1.1. 
1.4 Advantages and Disadvantages of Automation 
The benefits of using an automated analyser in haematology are numerous. These include speed, 
allowing a greater number of samples to be processed and results delivered to the clinician 
timeously. A result of these advantages is a reduction in technical staff required on the bench. 
Automated analysers assess in excess of 10,000 cells when determining FBCs, thus allowing for a 
high level of accuracy. Increased speed and accuracy when analysing routine samples allows for 
more time to be dedicated to verifying and further investigating abnormal results (13).  
However, automated haematology analysers are not without challenges (14). Although the 
differential count of mature leucocytes is done with excellent precision and accuracy by most 
automated analysers, enumeration of immature leucocytes and assessment of both red cell and 
platelet morphology is still better performed manually. 
Haematology analysers are renowned for being accurate in normal samples; however, there are 
situations in which these analysers provide artefactual results(14). Some of the reasons for this 
are highlighted in Table 1.2. 
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Table 1.2 Causes of spurious counts in haematology analysers 
 
 
Manual determination of a differential count (Diff) and review of the PBS remains the gold 
standard, but is unfortunately time consuming, labour intensive and expensive and should be used 
Cell Lineage Parameter Spurious result 
Red blood cells 
(RBC) 
Haemoglobin (Hb) Lipaemia causing increased turbidity and hence falsely 
increased Hb results 
High white cell count causing turbidity 
Raised immunoglobulins may falsely elevate Hb result 
Cryoglobulins may prevent light transmission in Hb 
measurement, thus falsely increasing Hb results 
 Red cell count 
(RCC) 
Giant platelets may be interpreted as red cells in an 
impedance based counter 
Cold or warm agglutinins causing red cell clumps will 
result in lower red cell counts (RCC) and spurious mean 
cell haemoglobin concentration (MCHC) & haematocrit 
(HCT). 
Microcytic red cells may be counted as platelets 
Cryoglobulins may cause a flow anomaly interfering with 
the RCC. 
White blood cells 
(WBC) 
 Neutrophil aggregation in vitro may cause decreased white 
cell count 
Platelet clumps and large platelets may mimic white cells 
Nucleated red blood cells may initially be included in the 
white cell count 
Cryoglobulins that cluster together may influence white 
cell count 
Platelets (PLTS)  Ethylenediamine tetra-acetic acid (EDTA) may cause 
platelet clumping resulting in pseudothrombocytopenia. 
Platelet sattelitism may cause a falsely decreased platelet 
count 
Large platelets may be assessed as white cells or red cells 
Red cell fragmentation may falsely increase platelet count 
Micro-organisms may be interpreted as platelets 
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judiciously (15).  In the face of qualified staff shortages, high sample volumes and turnaround 
time pressures, performing Diff counts and smear reviews manually undermines the efficiency 
and lowers the productivity of the laboratory.  
1.5 Consensus guidelines 
In 2005, the staffing pressures faced by clinical laboratories prompted the International 
Consensus Group for Haematology Review to establish a set of criteria (rules) to guide manual 
review of automated FBC and white blood cell Diff counts in order to reduce unnecessary smear 
review rates. The initial consensus rules were conceived and piloted in 17 laboratories in six 
countries (USA, Australia, Canada, United Kingdom, Spain and Switzerland).  From this pilot, 
consensus was reached on which situations should trigger a manual review of automated counter 
results as well as further actions including further testing. The consensus rules were then 
validated in these same countries. Each laboratory was asked to test 1000 samples.  A total of 
13 298 patient samples were analysed on 6 pre-selected haematology analysers: Abbott CellDyn 
4000 (Abbott Laboratories, Abbott Park, IL, USA), the ADVIA 120, the Beckman Coulter GenS 
and LH750 and the Sysmex SE-9000 and XE-2100. These analyses resulted in 41 rules for 
haematology review reached by consensus (see Appendix B).  Of these 41 rules, 15 relate to the 
FBC parameters, 7 to the differential parameters,  2 to reticulocytes  and 17 to  red cell, platelet 
and white cell instrument suspect flags. The application of these rules in the validation arm of the 
study revealed a false negative (FN) rate of 2.9 % (16). Of interest in this study, although it took 
place in different laboratories using different analysers, all laboratories had similar truth tables 
(that is, true positives (TP), true negatives (TN), false positives (FP) and FN).  Even having noted 
this, it is still vital that the rules be verified in each laboratory planning to implement them. There 
are a number of shortcomings and concerns with the ICGH consensus rules. For instance, the 
testing laboratories in the validation process were all in developed countries whose disease profile 
and available technology infrastructure is not the same as that seen in developing countries. These 
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rules were validated only in tertiary/referral laboratories but not throughout the whole spectrum 
of diagnostic laboratory services, and several subsequent reports evaluating the rule set have 
shown undesirably high FN rates (>5%)(17-20). In South Africa, very few studies evaluating the 
ICGH guidelines have been published, and all research in this regard to date has stemmed from 
academic centres.  Local validation and optimisation of the rules in non-academic laboratories 
using a variety of analysers is thus required. 
1.6 Clinically significant morphology 
In the same year as the ICGH published the consensus rules for smear review, the New England 
Journal of Medicine published an article by Barbara Bain about the importance of peripheral 
blood smear (PBS) assessment (15). Certain clinical scenarios benefit greatly from examination 
of the PBS, however, the clinical setting of the samples that come into the laboratory are not 
always known to laboratory staff. There are, however, laboratory indices which should trigger an 
evaluation of the PBS in order to assist in providing the requesting doctor with a differential 
diagnosis and aid in further workup of their patients. The clinical disorders where PBS 
examination may provide such information include anaemia, thrombocytopenia/thrombocytosis 
and leukaemia, lymphoma and bone marrow failure. Within the context of anaemia the following 
clinically significant disorders may be detected using PBS review: haemolytic anaemia (including 
hereditary causes and the life-threatening microangiopathic haemolysis as well as haemolysis 
caused by oxidant damage) and megaloblastic anaemia.  The value of PBS assessment in platelet 
count abnormalities lies in excluding pseudothrombocytopenia or falsely raised platelet counts as 
well as assessing possible causes including microangiopathic haemolysis, leukaemia/ lymphoma 
and malaria. It is imperative that cases of leukaemia or lymphoma be detected as early as possible 
and often the PBS evaluation is the first indication of such disorders (unexplained lymphocytosis, 
leucocytosis or monocytosis or a fortuitous finding) (15). All of these conditions present 
examples where examination of the PBS would provide vital information to the treating physician 
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and could be deemed clinically significant pathology. While this is not an exhaustive list of all 
clinically relevant pathology it may provide a minimum requirement of pathology that should not 
be missed when evaluating any rules for smear review used in a laboratory. 
1.7 Aim & Objectives 
Aim: To validate the ICGH rules for smear review in tertiary, regional and district NHLS 
laboratories and to optimise these rules for the South African disease burden.   
Objective 1: To determine the manual review rate of blood smears at tertiary, regional and district 
laboratories in the NHLS before and after application of the ICGH rules.  
Objective 2: To evaluate the false positive, false negative and efficiency rates before and after 
application of the ICGH rules.  
Objective 3: To optimise the rules at tertiary, regional and district laboratories in the NHLS. 
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2. Materials and Methods 
This study was approved by the Human Research Ethics Committee of the University of the 
Witwatersrand (Appendix C). 
2.1 Study Design 
The study was a prospective, non-interventional cross-sectional study conducted over a 3 month 
period from 1stJanuary to 31stMarch 2014. 
2.2 Study Setting 
The study was performed at health diagnostic laboratories from the tertiary, regional and district 
hospital tiers in the NHLS.  Table 2.1 provides the diagnostic laboratory tier; the size of the 
hospital serviced and test volumes of the selected laboratories (as provided by the respective 
laboratory managers).   
Table 2.1 Laboratory Demographics 
 Helen Joseph 
Hospital 
Tambo Memorial 
Hospital 
Sebokeng 
Hospital 
Dr Yusuf Dadoo 
Hospital 
Tier Tertiary Regional Regional District 
No. of beds 700 640 800 270 
Monthly volume over 
study period 
10180 FBCs 
&1061 Diffs 
6222 FBCs &     584 
Diffs 
4256 FBCs &   827 
Diffs 
540 FBCs &     119 
Diffs 
No. of morphologists 2 2 7 2 
Diff bench adequately 
staffed 
No Yes No Yes 
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These laboratories represent each tier in the South African health system as defined by the 
Regulation for the Designation of Public Hospitals laid out in the National Health Insurance 
(NHI) white paper released in December 2015 (21).  Public hospitals are categorised into 5 tiers 
(Appendix D). 
As a comprehensive study of the ICGH guidelines for smear review had already been performed 
at central hospital level (Charlotte Maxeke Johannesburg Academic Hospital) (22),the district, 
regional and tertiary laboratories were chosen to represent the diagnostic tiers.  
The specific laboratories chosen were selected as they were representative of not only a wider 
area of Gauteng (East Rand (Tambo Memorial), West rand (Dr Yusuf Dadoo), South Gauteng 
(Sebokeng) and Central Gauteng (Helen Joseph)) but also represented the most commonly used 
analyser from each tier at the time this study was commenced.  The Beckman Coulter Act5 Diff 
(Beckman Coulter Inc., California, USA), the Sysmex XT2000i (Sysmex, Kobe, Japan) and the 
Advia 2120 (Siemens healthcare diagnostics, NY, USA) were assessed in the district, regional 
and tertiary tiers respectively. Table A.1 in Appendix A summarises the three analysers assessed 
in this study.  
2.3 Study Population and Eligibility Criteria 
2.3.1 Inclusion and exclusion criteria 
The peripheral blood samples used in the study were selected from the FBC and/or FBC and Diff 
samples analysed as part of the routine laboratory workload in the various hospital tiers. A 
request was submitted for 10 random samples to be selected each day over the three month period 
per laboratory. Samples were randomly selected in order to achieve a representative sample of 
each laboratory’s patient population. Selection based on FBC counts or instrument generated 
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flags was discouraged in order to avoid selection bias. Exclusion criteria are summarised in Table 
2.2. 
Table 2.2 Exclusion Criteria 
Exclusion Criteria 
Inadequate staining of the PBS 
EDTA or storage-related changes  
Samples referred from clinics or sickbays with extended transport times (>48 hours) 
Samples with inadequate volume (<4 ml) 
Samples with a delay in reaching the respective laboratory where FBC/Diff was run 
Results which indicated partial aspiration by the instrument 
2.4 Data Collection 
2.4.1 Assessment of manual review rates before implementation of the ICGH rules 
In order to assess the manual review rates before implementation of the ICGH rules, the 
respective laboratory SOPs for smear review and abnormal FBC results were obtained. These 
SOPs were assessed to answer three questions. 1) What are the thresholds for smear review for 
the FBC and Diff count parameters? 2) Does the laboratory make use of morphology 
abnormalities flagged by the respective analysers? 3) If so, which flags do they use?  The 
laboratory manager or pathologist in charge of the laboratory was also questioned on the 
operational requirements and client satisfaction that the current smear review practices provided. 
The aim of this line of questioning was to determine the operational need to implement a new 
system for smear review and whether a reduction in smear review rates was, in fact, required. The 
information collected included number of staff on the morphology bench, number of samples 
being requested for smear review and any specific concerns raised by the NHLS clients in view of 
FBC and Diff count results (See Appendix E). 
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2.4.2 Assessment of manual review rate after using the ICGH rules 
The manual review rates after implementation of the ICGH rules were then assessed and 
compared to the manual review rate using the current laboratory SOP. Both assessments were 
performed on the same samples. 
2.4.3 Laboratory Methods 
Ten randomly selected FBC requests (with or without Diff counts) were sampled from each 
laboratory tier daily. The samples were collected into Ethylenediamine tetra-acetic acid (EDTA)-
K
2 
(Becton Dickinson, USA) blood tubes as per laboratory manual and run within 2 hours of 
sample collection where possible. Each sample was run as per laboratory SOP for standard FBC 
and Diff request. Daily quality controls were performed as well as external proficiency testing. 
 
For each specimen a stained blood film (May-Grünwald Giemsa) was prepared for morphologic 
assessment. A printout was made of the accompanying counts, scatter plots (if available) and 
morphology flags. Manual peripheral blood smear (PBS) review was performed on all the films 
by an experienced technologist in each laboratory and subsequently reviewed by the investigator. 
Any smears not initially reviewed by the attending technologist were reviewed by Dr K Mannaru, 
a consultant haematologist. 
 
Each sample was assessed using both the laboratory SOP and the ICGH rules and manual review 
rates compared. The indications for manual review were noted for each sample. A positive smear 
result was defined as per the ICGH criteria (see Table 2.3). 
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Table 2.3 Peripheral smear criteria (as per ICGH criteria) 
Peripheral Smear Criteria 
 RBC morphology at 2+/moderate or greater 
 Malaria 
 Giant platelets (PLTs) at 2+/moderate or greater 
 PLT clumps at greater than 1+/mild 
 Dohle bodies/toxic granulation/vacuoles at 2+/moderate or greater 
 Blasts at 1 or greater 
 Metamyelocytes at greater than 2 
 Myelocytes/ promyelocytes at 1 or greater 
 Atypical lymphocytes at greater than 5 
 Nucleated red blood cells (NRBCs) at 1 or greater 
 Plasma cell at 1 or greater 
 
Each sample was allocated a research specific number in order to determine total number of 
samples and allowing for elimination of any unique patient identifying information.  
The data was recorded on pre-designed data collection sheets (See Appendix F) 
2.5 Data Analysis: 
2.5.1 Analytical methods 
Data was allotted in 2x2 truth tables and true/false positive, true/false negative and efficiency 
rates using the ICGH rules at each laboratory were assessed. A FN rate of <5% was set as 
threshold of acceptance (as recommended in the ICGH guidelines) (16). The sensitivity and 
specificity of each FBC parameter flag (white cell count (WCC) <4 or >30 x 109/L, HB <7g/dL 
or >2g/dL more than upper limit of normal, MCV<75 or >105 fl, red cell distribution width 
(RDW)>22% and platelets <100 or>1000 x 109/L) were determined for the detection of any 
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abnormality. Parameters within the same lineage were then combined (where possible) and the 
sensitivity and specificity for the detection of lineage specific abnormalities also calculated; i.e. 
samples with parameter rule violations related to the WCC were assessed for white cell 
morphology abnormalities, those with red cell parameter rule violations (HB/MCV and RDW) 
were assessed for red cell abnormalities, and those with platelet parameter rule violations were 
assessed for platelet abnormalities.  
The sensitivity, specificity, FP and FN rates of the clinically significant analyser-generated 
morphology flags for each lineage were assessed in two ways: 
 For the specific morphological abnormality flagged (e.g. normoblasts seen 
morphologically where normoblasts which were flagged). 
 For morphologic abnormalities in the same cell lineage as the morphology flag (e.g. any 
red cell abnormalities where normoblasts were flagged).  
The truth table information garnered from the flags that were triggered in 15 or fewer samples 
were analysed but the results were treated with reserve in view of the small sample size.  
Samples with FP flagging were then more closely analysed in order to identify flags which trigger 
unnecessary review, thereby facilitating optimisation of the ICGH rules for the local setting.  
For the flags commonly triggered in FP samples, close attention was paid to specimens where 
these flags were triggered in isolation so as to determine the effect of excluding these flags from 
the rule-set. 
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2.6 Statistical analysis 
Data was captured on excel spreadsheet (Microsoft Office 2007, Redmond, USA) and analysed 
using GraphPad Prism(GraphPad Software, California, USA). 
In the context of this study, the samples were defined as being true/false positive or negative as 
follows (16): 
 True positive (TP): if a rule was triggered and this corresponded with a positive finding 
on the smear (for criteria for a positive smear see Table 2.4) 
 False positive (FP): if a rule was triggered and a positive result was not found on smear 
review.   
 False Negative (FN): if a rule was not triggered and a positive finding was noted on the 
smear. 
 True negative (TN): if a rule was not triggered and no positive smear finding was 
detected. 
All rates were calculated as a proportion of all included samples for each laboratory tier. 
Sensitivity was calculated using the following formula: TP/ (TP+FN) x 100 
Specificity calculated using the following formula: TN/ (TN+FP) x 100 
The efficiency of each analyser was determined using the following formula: 
Efficiency = (TP + TN)/All samples (TP+FP +TN+FN) x 100.  
A Mann-Whitney U test was used to compare the manual review rates between different rule 
sets. A P value of <0.05 was considered statistically significant. 
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3. Results 
3.1 Feedback from Laboratory Managers 
The laboratory managers from the four laboratories which took part in this study gave their 
feedback with regards to staffing requirements and Department of Health complaints (Table 2.1). 
None of the laboratories reported having difficulties with Department of Health in terms of TAT 
complaints except when the laboratory LIS is not functioning optimally. 
HJH, Tambo Memorial Hospital and Yusuf Dadoo Hospital all have two technologists competent 
in morphology. The haematology supervisor also aids in peripheral smear morphology at HJH 
when required.  
3.2 Study population 
A total of 600 samples were assessed from the three laboratory tiers (260 from the tertiary 
laboratory, 200 from the regional laboratories and 140 from the district laboratory).The pertinent 
demographic data and data by clinical division are summarised in Tables 3.1 and 3.2.  
Table 3.1 Pertinent demographic data 
IQR: Interquartile range 
 HJH (Tertiary) Tambo 
Memorial/Sebokeng 
(Regional) 
Dr Yusuf Dadoo 
(District) 
Total samples (N) 260 200 140 
 FBC (N) 90 45 118 
FBC/Diff (N) 170 155 22 
Male (N) 110 94 68 
Female (N) 140 101 72 
Unspecified gender (N) 10 5 0 
Median age in years 
[median(IQR)] 
38.0 (27-53) 36.0 (20-48) 37.0 (31-45) 
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Table 3.2 Data by clinical division  
 
3.3 Comparison of manual review rates between the current laboratory SOP 
and the ICGH rules  
 
3.3.1 Manual review rates 
The results of the manual review rates using the laboratory SOP versus implementation of the 
ICGH rules varied between laboratories depending on how restrictive the SOP rules were.  
3.3.1.1 Advia 2120 [HJH]: 
Two hundred and sixty samples were reviewed from the tertiary laboratory and cytopenias 
accounted for the majority of abnormal parameters, while samples with cytoses were few (Fig. 
3.1). Implementation of the ICGH rules showed a statistically significant reduction in the manual 
review rate (82% vs 70%; p=0.022). The indications for smear review using the lab SOP included 
Diff count requested by the physician (171/260; 66%) and thrombocytopenia (67/260; 26%) 
while the indications for smear review using the ICGH rules included analyser morphology flags 
 HJH (Tertiary) Tambo 
Memorial/Sebokeng 
(Regional) 
Dr Yusuf Dadoo 
(District) 
Medical ward (%) 40.7 18.0 26.4 
Surgical ward (%) 4.6 19.0 7.9 
Paediatric ward (%) 3.4 8.0 1.4 
ARV clinic (%) 5.3 7.0 26.9 
Outpatients (%) 9.6 9.0 15.3 
ICU (%) 4.6 10.0 3.5 
Admissions (%) 8.4 16.5 10.0 
Emergency (%) 10.0 1.5 8.6 
Not recorded (%) 13.4 11.0  -  
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(172/260; 67%), WCC <4 x 109/L (8/260; 20%), WCC >30 x 109/L (5/260; 2%), Hb <7g/dL 
(29/260; 11%), Hb >2+ upper limit (5/260; 2%), PLTS <100 x 109/L (68/260; 26%), MCV <75 fl 
(16/260; 6%), MCV >105 fl (21/260; 8%) and RDW >22% (16/260; 6%).  
3.3.1.2 Sysmex XT2000i [Tambo Memorial/Sebokeng]: 
Two hundred samples were obtained from the regional laboratories, where the SOP used was 
based broadly on the ICGH rules with some adjustments. There was no available documentation 
regarding the validation of these rules.  There was no significant increase in manual review rate in 
the regional tier laboratory (72% vs 80%; p = 0.198).  The indications for smear review included 
parameter abnormalities for both the lab SOP and ICGH rules. The main difference between the 
two groups was the addition of morphology flag assessment in the ICGH cohort which accounted 
for 68% of the samples manually reviewed.  
3.3.1.3 Beckman Coulter Act5diff [Dr Yusuf Dadoo]: 
One hundred and forty samples were obtained from the district laboratory, where the SOP used 
was similar to that used in the regional laboratory. Significantly more slides were manually 
reviewed when the ICGH rules were applied (67% vs 79%; p <0.0001). The indications for smear 
review were similar in both groups with the primary difference being the WCC<4 x 109/L used by 
ICGH versus WCC <2 x 109/L used in the lab SOP. 
3.4 Comparison of analyser flags and morphology findings  
The proportion of FBC parameters and morphology flags which triggered peripheral smear 
review in the sample populations of the different diagnostic tiers are depicted in Figures 3.1 and 
3.2 respectively.  
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(WCC: white cell count; HB: Haemoglobin; MCV: mean cell volume; PLTS: platelets). 
Figure 1 Proportion of abnormal parameters as a percentage of all samples per tier.   
 
Leukopenia and thrombocytopenia were the most common parameter flags triggered in the 
tertiary hospital, while anaemia and microcytosis were most prevalent in the regional facility 
(Fig. 1). The most common abnormal parameter in the district laboratory was leucopenia 
(WCC<4 x 109/L), with <10% of samples having anaemia or thrombocytopenia. 
The analysers from the different tiers triggered the different morphology flags variably (Fig 2) 
based on the sample population collected at the respective laboratories and instrument generated 
flags specific to each analyser. 
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(HC VAR:variation in haemoglobin concentration, NRBC: nucleated red blood cells, LS: left shift, IG: immature 
granulocytes, ALYM: atypical lymphocytes, PCL: platelet clumping 
Figure 2 Proportion of individual flags as a percentage of total flags per tier 
 The majority of peripheral blood morphology abnormalities appear to mirror one another in the 
three tiers with the exception of a few cases (Fig. 3). 
 
 
(NRBC: nucleated red blood cells, TC: target cells, PC: pencil cells, TD: teardrops, MACRO: macrocytosis, DIM: 
dimorphic blood picture, RF: rouleaux formation, ANISO: anisocytosis, ELLIP: elliptocytes, FRAG: red cell fragments, SC: 
sickle cells, SPH: spherocytes, LP: large platelets, PCL: platelet clumping, TG: toxic granulation, ALYM: atypical 
lymphocytes, LS: left shift) 
Figure 3 Commonest peripheral smear findings from each laboratory tier as a proportion of all 
samples assessed. 
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Table 3.3 summarises the most pertinent morphology findings from each diagnostic tier.  
Table 3.3 Peripheral blood morphology in different laboratory tiers 
Tertiary tier  
[HJH]:  
Regional tier 
[Tambo Memorial/ Sebokeng]: 
District tier 
[Dr Yusuf Dadoo]: 
Greater number of 
smears with NRBCs 
were noted 
Samples with teardrops, LS 
and toxic granulation were 
more commonly seen.  
 
RF, ALYM, LS and PCL most 
commonly noted. 
NRBCs were seen in only 6% of 
samples, despite the analyser having 
flagged for this abnormality in ~45% 
of the included specimens.  
 
3.5 Truth tables and false negative/positive analyses 
3.5.1 Tertiary laboratory: Helen Joseph Hospital (Advia 2120) 
Table 3.4 summarises the changes in FN rate, FP rate, sensitivity, specificity and efficiency 
between the laboratory SOP and implementation of the ICGH rules.  
Table 3.4 Truth table comparing laboratory SOP with ICGH rules 
 Laboratory SOP ICGH Rules 
False negative rate [n/N(%)] 31/260 (11.9) 15/260 (5.8) 
False positive rate [n/N(%)] 81/260 (31.2) 40/260 (15.4) 
Sensitivity (%) 80.8 89.4 
Specificity (%) 17.3 59.6 
Efficiency (%) 56.9 78.1 
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Tables 3.5-3.7 are the truth tables for morphology flags, general lineage parameter flags and 
individual parameter flags respectively. These tables summarise the best and worst performing 
individual flags for both morphology and parameters. 
Table 3.5 Tertiary laboratory morphology truth table 
 Sensitivity 
(%) 
Specificity 
(%) 
Efficiency 
(%) 
False Negative 
(%) 
False Positive 
(%) 
HC VAR for RBC  43 87 75 17 10 
NRBC for NRBC  30 90 83 9 9 
NRBC for RBC  25 94 72 24 4 
FRAGS for fragments - - - - - 
Left shift for LS  47 92 82 12 6 
Left shift for WBC 40 94 82 19 4 
Immature granulocytes for IG  40 96 83 13 3 
Immature granulocytes for WBC  32 98 77 22 2 
Blasts for blasts 45 88 86 2 12 
Blasts for WBC  23 91 70 25 6 
Atypical Lymphocytes  13 97 84 13 2 
Large platelets for LP  25 96 90 7 4 
Large  platelets for PLTS  21 97 88 10 3 
Platelet clumping for PCL  40 98 96 2 2 
Platelet clumping for PLTS  12 98 87 12 2 
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Table 3.6 Parameter truth table per lineage 
Lineage  Sensitivity (%) Specificity (%) Efficiency (%) False Negative (%) False Positive (%) 
White cells 26 81 58 30 12 
Red cells 52 87 76 15 9 
Platelets 34 76 71 83 21 
Each parameter was assessed with regard to morphologic abnormalities in their specific cell line i.e. white cell 
abnormalities assessed in those samples with white cell parameter abnormalities. 
Table 3.7 Individual parameter truth table 
 Sensitivity 
(%) 
Specificity 
(%) 
Efficiency 
(%) 
False Negative 
(%) 
False Positive 
(%) 
White cells count <4 x 10^9/L 23 81 56 43 11 
White cell count>30 x 10^9/L 3 99 58 43 0.5 
Haemoglobin<7g/dl 20 93 72 44 5 
Haemoglobin >2 of upper limit 3 98 69 67 2 
MCV<75fl 16 98 73 19 1 
MCV>105fl 16 97 71 30 2 
RDW>22 16 98 73 19 1 
Platelets<100 x 10^9/l 34 76 71 83 21 
Platelets >1000 x 10^9/L - - - - - 
 
3.5.1.2 Analysis of samples with false positive flagging 
Because FP flagging results in increased manual review rates, flagged samples with no 
morphological abnormalities were assessed in order to identify flags which trigger unnecessary 
review most frequently in normal samples. From the 40 samples that were assessed to FP using 
the ICGH rules, 25/40 (62.5%) were owing to morphology flags being triggered (Table 3.8).  
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Table 3.8 Analysis of false positive samples at the tertiary site 
Flag triggered in false 
positive sample 
Number of samples in 
which flag was 
triggered (N=40) [n 
(%)] 
Triggered in isolation (i.e. no other morphology or 
parameter abnormality triggered) 
(Yes/total) 
HCVAR 11/40 (27.5) 3/11 
NRBC 4/40 (10.0) 1/4 
Left shift 6/40 (15.0) 4/6 
Immature granulocytes 1/40 (2.5) 0/1 
Blasts 3/40 (7.5) 0/3 
Atypical lymphocytes 1/40 (2.5) 0/1 
Large platelets 3/40 (7.5) 0/3 
 
The most commonly triggered flags in samples with FP review were the haemoglobin 
concentration variation (HCVAR), left shift (LS) and WCC <4 x 109/L flags (the latter 
particularly in samples with a WCC from 2-3.99x109/l). The HCVAR flag was flagged in 
isolation in only three samples (n=11, 27.2%) while the LS flag was triggered in isolation in four 
samples (n=6, 66.7%).  
The HCVAR flag was triggered in 42 samples assessed as being TP. In four of these (n=42, 11%) 
the HCVAR flag was triggered in isolation. The morphology findings noted in these four samples 
included; a leukoerythroblastic reaction (with moderate LS and toxic granulation (TG)), 
spherocytes, ALYMs>5, and moderate target cells (TC) with nucleated red blood cells (NRBCs) 
(4/100 WBC) respectively. Out of all samples assessed, the HCVAR flag was triggered in 
isolation in nine (n=260, 3.4%).  
The LS flag was triggered in 44 samples, 38 of which were TP (n= 44, 84%). Four of these 
samples had LS in isolation. A single sample which flagged LS, demonstrated 1% blasts with 
toxic changes (LS and TG), Blasts or ALYMs were not flagged by the analyser. In view of the 
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morphology findings, ongoing monitoring of the counts and PBS review was indicated. As a 
proportion of all tertiary laboratory samples, 8 (n=260, 3%) had a LS flag in isolation.  
The WCC was 2-3.99 x 109/L in 48 samples, of which 32 (n=48, 66.7%) were TP. This flag 
triggered in isolation in 10 instances, of which two (n=10, 20%) were TP. The morphology in 
these samples included TG, ALYMs, rouleaux formation (RF), TC, large platelets and PCL with 
a platelet count <100x10^9/L.  
3.4.2 Regional Laboratory Results: Tambo Memorial & Sebokeng Hospital 
(SysmexXT2000i) 
 
Table 3.9 summarises the FN, FP, sensitivity, specificity and efficiency of the laboratory SOP 
versus implementation of the ICGH rules, showing an improvement in FN rate and sensitivity but 
at the expense of an increased FP rate and reduced efficiency. 
Table 3.9 Truth table comparing laboratory SOP with ICGH rules 
 Laboratory SOP ICGH Rules 
False negative rate [n/N(%)] 11/200 (5.0) 7/200 (3.5) 
False positive rate [n/N(%)] 35/200 (17.5) 43/200 (21.5) 
Sensitivity (%) 90.8 94.2 
Specificity (%) 56.3 44.9 
Efficiency (%) 77.0 74.5 
 
Tables 3.10 – 3.12 summarise the truth tables for morphology flags, general lineage parameter 
flags and individual parameter flags for the regional tier laboratories and highlight the best and 
worst performing individual flags.  
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The sensitivity of the morphology flags was overall poor for both general and specific 
morphology findings but marginally better for the specific morphology (Table 3.10).  
Table 3.10 Regional laboratory truth table 
 Sensitivity 
(%) 
Specificity 
(%) 
Efficiency 
(%) 
False Negative 
(%) 
False Positive 
(%) 
NRBC for NRBC (%) 30 89 87 3 11 
NRBC for RBC (%) 22 92 73 21 6 
Left shift for LS (%) 24 95 82 14 4 
Left shift for WBC (%) 22 96 77 20 3 
Immature granulocytes for IG (%) 71 82 78 5 15 
Immature granulocytes for WBC (%) 63 84 77 9 12 
Blasts for blasts (%) 33 91 90 1 8 
Blasts for WBC (%) 17 93 75 20 5 
Atypical Lymphocytes (%) 56 87 82 6 11 
Atypical lymphocytes for WBC (%) 30 87 68 23 9 
Platelet clumping for PCL (%) 61 80 79 4 18 
Platelet clumping for PLTS (%) 54 81 78 6 17 
 
Table 3.11  Parameter flag truth table 
 Sensitivity Specificity Efficiency False Negative False Positive 
White cells [%] 21 86 66 25 10 
Red cells [%] 57 67 67 13 24 
Platelets [%] 15 91 81 11 8 
Each parameter was assessed with regard to morphologic abnormalities in their specific cell line i.e. white cell abnormalities 
assessed in those samples with white cell parameter abnormalities 
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Table 3.12 Individual parameter flag truth table for the regional tier laboratories 
 Sensitivity Specificity Efficiency False Negative False Positive 
White cells count <4 x 10^9/l [%] 9 87 62 30 9 
White cells count >30 x 10^9/l [%] 9 99 69 30 1 
Haemoglobin<7g/dl [%] 34 82 69 18 14 
Haemoglobin>2g/dL of upper limit 
[%] 
- - - - - 
MCV<75fl [%] 28 87 70 21 10 
MCV>105fl [%] 7 96 76 26 3 
RDW>22 [%] 29 97 78 20 2 
Platelets<100 x 10^9/l [%] 15 91 81 11 8 
Platelets>1000x 10^9/l [%] - - - - - 
 
3.4.2.2 Analysis of samples with false positive flagging 
From the 44 samples that were assessed to be FP using the ICGH rules (Table 3.13), 30 (n=44, 
68.2%) were owing to morphology flags being triggered, 8 (n=44, 18.2%) were attributable to the 
WCC<4 x 109/L parameter rule (all of which were triggered in samples with a WCC 2-3.99 x 
109/l) and 6 (n=44, 13.6%) were attributable to Hb<7 g/dL. 
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Table 3.13 Analysis of false positive samples at the regional sites 
Flag triggered in false positive 
sample 
Number of samples in 
which flag was 
triggered (N=44) 
[N (%)] 
Triggered in isolation (i.e. no other morphology or 
parameter abnormality triggered) 
(Yes/total) 
NRBC 2 (4.4) 0/2 
Left shift 1 (2.2) 0/1 
Blasts 3 (6.7) 0/3 
Atypical lymphocytes 9 (20.0)  2/9 
Immature granulocytes 9 (20.0) 4/9 
Platelet clumping 13 (28.9) 4/13 
 
The flags most frequently triggered in FP samples, the ALYM, IG, PCL and WCC 2-3.99 x 109/L 
flags were analysed further. The ALYM flag was triggered in 38 samples, of which 29 (n=38; 
76.3%) were TP. This flag triggered alone in five instances (n=38; 13.2%), of which three were 
regarded as TP.  All of these samples had ALYMs reported morphologically. 
The IG flag was triggered in 58 samples of which 48 (n=58; 82.7%) were TP and 10 were 
triggered in isolation.  Six of the latter samples (n = 10; 60%) were regarded as TP. The 
morphology findings included: one sample with a morphological finding of blasts (<20% of total 
white cells), while the others showed features of infection (LS and/or TG) and ALYMs.  
The PCL flag triggered in 47 samples, and was TP in 34 (n = 47; 72.3%) of these. It triggered in 
isolation in six cases, two of which were TP as PCL was detected. In the TP cases, both of these 
samples had normal platelet counts and the finding was not clinically significant.  
The WCC 2-3.99 x 109/L flag triggered in 20 samples, of which 11 (n=20, 55.0%) were TP. This 
flag triggered in isolation in 4 instances, all of which were FP.  
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The Hb<7g/dL flag was triggered in 45 samples of which 5 (n=45, 11.1%) were triggered in 
isolation. Four of these (n=5, 80%) were assessed as being FP with one TP sample (n=5, 20%). 
The TP sample had a Hb of 5.0g/dL with a morphological finding of TG.  
3.4.3 District Laboratory Results: Dr Yusuf Dadoo Hospital (Beckman Coulter) 
Act5diff 
The changes noted on implementation of the ICGH rules in the district laboratory are summarised 
in Table 3.14.  
Table 3.14 Truth table comparing laboratory SOP with ICGH rules 
 Laboratory SOP ICGH Rules 
False negative rate [n/N(%)] 45/140 (32.1) 7/140 (5.0) 
False positive rate [n/N(%)] 9/140 (6.4) 37/140 (26.4) 
Sensitivity (%) 43.8 91.4 
Specificity (%) 84.7 37.3 
Efficiency (%) 60.7 68.6 
 
Tables 3.15 – 3.17 summarise the truth tables for the district tier laboratory. These tables include 
morphology flags, general parameter flags and individual parameter flags respectively, 
highlighting the best and worst performing flags.  
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Table 3.15 District laboratory morphology truth table 
 Sensitivity Specificity Efficiency False Negative False Positive 
NRBC for NRBC (%) 66 39 36 1 52 
NRBC for RBC (%) 58 38 37 7 45 
Fragments for Fragments (%) 66 96 94 1 4 
Fragments for RBC (%) 11 97 74 24 2 
Left shift for LS (%) - - - - - 
Left shift for WBC (%) - - - - - 
Immature granulocytes for IG (%) - - - - - 
Immature granulocytes for WBC (%) - - - - - 
Blasts for blasts (%) - - - - - 
Blasts for WBC (%) - - - - - 
Atypical Lymphocytes (%) - - - - - 
Atypical lymphocytes for WBC (%) - - - - - 
Platelet clumping for PCL (%) 57 81 78 4 17 
Platelet clumping for PLTS (%) 58 84 79 7 13 
 
Table 3.16 Parameter flag truth table 
 Sensitivity Specificity Efficiency False Negative False Positive 
White cells [%] 26 87 69 23 9 
Red cells [%] 46 83 73 14 13 
Platelets [%] 17 96 83 14 4 
Each parameter was assessed with regard to morphologic abnormalities in their specific cell line i.e. white cell abnormalities 
assessed in those samples with white cell parameter abnormalities 
 
 
 
 
33 
 
Table 3.17 District laboratory parameter truth table 
 Sensitivity Specificity Efficiency False Negative False Positive 
White cells count <4 x 10^9/l [%] 26 87 69 23 9 
White cells count >30 x 10^9/l [%] - - - - - 
Haemoglobin<7g/dl [%] 26 98 78 21 1 
Haemoglobin<2g/dL of upper limit 
[%] 
- - - - - 
MCV<75fl [%] 24 94 74 22 4 
MCV>105fl [%] 3 91 66 27 6 
RDW>22 [%] - - - - - 
Platelets<100 x 10^9/l [%] 17 96 83 14 4 
Platelets<100 x 10^9/l [%] - - - - - 
 
3.4.3.2 Analysis of samples with false positive flagging 
From the 37 samples that were assessed to be FP using the ICGH rules, 34 were owing to 
morphology flags being triggered (Table 3.18).  
Table 3.18 Analysis of false positive samples 
Flag triggered in false positive 
sample 
Number of samples in 
which flag was 
triggered (N=37) 
[N (%)]) 
Triggered in isolation (i.e. no other morphology or 
parameter abnormality triggered) 
(Yes/total) 
NRBC 31 (83.8) 22/31 
Platelet clumping 3 (8.1) 0/3 
 
The only flags triggered as FP were the NRBC and PCL flags. The latter was never triggered in 
isolation and all three samples had platelet counts >100 x 109/L. The other flags triggered in 
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conjunction with the PCL flag included WCC < 4 x 109/L (in 2/3) and NRBC flag (in all three). 
These samples would, therefore, have been manually assessed for another reason.  
The WCC <4 x 109/L flag triggered in 23 samples, of which 19 (n=23, 82.6%) were TP. This flag 
triggered in isolation in 4 instances. This included 3 samples assessed as TP and one FP sample. 
The morphology detected included RF in three samples and ALYMs in one.  
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4. Discussion 
 
In an effort to standardise the criteria for smear review across laboratories in all the health tiers in 
the Johannesburg area, the ICGH rules for smear review were validated using a cross sectional 
representative sample of FBC and Diff count analyses. Six hundred FBC samples with or without 
an accompanying Diff count were used in the validation of the ICGH rules and compared to the 
current laboratory SOPs. The manual review rates, FN and FP rates were evaluated and from 
these results sensitivity, specificity and efficiency were calculated.   
4.1 Manual review rates 
The implementation of rules for smear review resulted in a reduction of manual PBS review rates 
across all diagnostic health laboratory tiers in the sample of laboratories examined. The 
laboratories assessed in this study all had SOPs outlining the rules for smear review used, but 
none had clear evidence for the chosen approach nor was there a clearly documented validation of 
these rules. Of concern was the lack of standardisation of the rules determining manual smear 
review between the different diagnostic laboratories which only served to highlight the need for 
investigation into one standardised approach for all laboratories within a laboratory tier and an 
analyser-specific optimisation protocol based on validation results.   
In the tertiary laboratory (HJH), 66% of smear reviews were performed in samples which had a 
Diff count requested, with a further 27% of the samples being manually reviewed because of 
thrombocytopenia (Plts <140 x 109/L). Implementation of the ICGH rules in this sample 
population saw a statistically significant decline in the number of slides manually reviewed (from 
82% to 70%; p=0.02). It should be noted that in the daily functioning of the laboratory ~10% of 
the total FBC requests have an accompanying Diff count request as compared with 66% in this 
study population. The smear review rates reflected here using the current laboratory SOP are thus 
likely to be inflated. Nonetheless, these findings support that a Diff count request alone need not 
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be a criterion for manual review of the peripheral smear. A similar recommendation was made by 
the Francophone group, who suggested that physician opinion alone not be a criterion for smear 
review except in haematology-oncology patients (20). 
The regional tier laboratories (Tambo Memorial Hospital and Sebokeng Hospital) use a SOP 
based on the modified ICGH rules with some adjustments, however, it was unclear to what extent 
these rules had been validated in these laboratories. The manual review rate increased marginally 
in the regional laboratory but this was not statistically significant. The main reason for this was 
the inclusion of analyser morphology flags as criteria for slide review (which were not used in the 
laboratory SOP). A WCC of <4 x 109/L as the threshold for smear review versus 2 x 109/L in the 
laboratory SOP also contributed to the increased review rate. As the majority of samples came 
from patients of African descent (who are known to have lower WCCs (23)), an argument could 
be made for the reduction of this cut-off to reduce unnecessary smear review.  
The district laboratory (Dr Yusuf Dadoo) used the same SOP as the regional laboratory with the 
addition of morphology flags. There was a statistically significantly increase in the review rate 
with implementation of the ICGH rules in this tier (79.3% vs 67.1%; p <0.0001). The main 
contributor to this difference was the stricter WCC threshold (4 x 109/L vs 2 x 109/L).  
The review rates noted in the current study using the ICGH rules in all three tiers (70.0% in the 
tertiary laboratory, 79.5% in the regional laboratory and 79.2% in the district laboratory) are 
higher than those documented in several other studies evaluating the ICGH rule set. Eldanasoury 
et al from Egypt compared the ICGH criteria for smear review to their current laboratory smear 
review criteria and found that the review rate dropped from 71% to 54.25% on implementation of 
the ICGH rules (17). On implementation of the ICGH rules by Comar et al from Brazil, the 
manual review rate was reduced to 46.03%(18). Pratumvinit et al in Thailand compared the 
ICGH rules to their laboratory criteria and then to optimised criteria and found manual review 
rates of 29.33% using the ICGH consensus rules. (24). In their comparison study of the rates of 
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manual peripheral blood smear review using the Advia 2120 (Siemens Healthcare Diagnostics, 
NY, USA), UnicelDxH 800 (Beckman Coulter, Inc, Brea, California, USA) and SysmexXE2100 
(Sysmex corporation, Kobe, Japan), Kim et al found manual review rates of 20.2%, 22.8% and 
28.6% respectively (19). The reason for this discrepancy of review rates with the published 
literature may be population-specific, reflecting genetic differences among South Africans or a 
different pathology profile (particularly a higher burden of infectious diseases due to the HIV 
epidemic).  Comparison of implementation of the ICGH consensus rules with other Sub-Saharan 
African countries was not possible as similar studies have not been published. The closest 
comparison is with a study done in South Africa by Joubert et al(25), who looked at the inbuilt 
flagging capability of the Sysmex XT-series analysers and found “positive” flagging in 63.7% of 
samples, a number much closer to those seen in this study. Optimisation of the rules in the South 
African setting is clearly required to reduce these rates in light of the shortage of staff skilled in 
morphology. Possibly, the criteria used for defining positive smear findings should be re-
evaluated to take into account our unique population, pathology and labour constraints, so that 
morphology findings which are not clinically critical are given less weight when determining the 
FN rates, and validating/optimising smear review rules. 
In the South African context of high workload owing to increased burden of infectious disease eg. 
HIV and Tuberculosis (TB), rules that reduce the manual PBS review rate, particularly in the 
more scarcely staffed regional and district laboratories, would allow the small complement of 
staff to focus on the truly pathological samples and provide a better diagnostic service.  
4.2 Parameter evaluation 
A greater proportion of samples with cytopenias (146/260, 56%) were received from the tertiary 
tier laboratory. This is an intuitive finding as one would expect patients at this hospital to have 
more severe cytopenias, being a referral hospital for both regional and district hospitals. A greater 
proportion of samples triggering parameter flags would require a greater number of staff 
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competent in morphology which was not the case in this study as the tertiary laboratory had the 
same number of morphologists as the district laboratory and fewer than the regional laboratory.  
4.2.1 Tertiary tier laboratory (HJH) 
The sensitivity for the parameter flags was poor, with all but the flag for a platelet count 
<100x109/l having a sensitivity >30%. (Table 3.7) The FN rate for the parameter flags was also 
extremely poor, being ≥ 30% in all but the flag for a MCV<75fl or a RDW >22.  
When the parameter flags were assessed per lineage (and not per parameter), collectively the red 
cell, white cell and platelet lineage parameter flags did not show much improvement when 
reviewed in conjunction with general morphology findings per cell lineage, with only the 
combined red cell flags demonstrating a sensitivity >50% (Table 3.6). The FN rate for the 
parameter flags was also extremely poor, being ≥ 30% in all but the red cell flags (Table 3.6). 
Overall efficiency was poorest in the white cell flags, largely due to flagging in samples with a 
WCC< 4 x 109/L. This was particularly true among those with a WCC from 2-3.99x109/l, with 16 
(n=48, 33.3%) cases with a WCC in this range being FP.  However, when the rules were applied 
collectively (over all lineages in all samples), the sensitivity of the ICGH rules approached 90%, 
with a FN rate only marginally above the recommended threshold of 5% owing to the small 
number of pathological samples in each subgroup (Table 3.4). 
4.2.2 Regional tier laboratories (Tambo Memorial/Sebokeng) 
As was seen in the tertiary laboratory, the sensitivity of the parameters was poor, particularly for 
the white cell and platelet flags. The only parameter with a sensitivity >30% was Hb<7g/dL 
(Table 3.12). The WCC<4x109/l had the poorest efficiency rate (62%), with 8 (n=20, 40%) of 
those with a WCC from 2-3.99x109/l being FP samples.  
When the lineage parameters were combined, the specificity was excellent for white cell and 
platelet parameters and still >60% for red cell parameters (Table 3.11). Red cell parameters were 
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the only lineage with a sensitivity >50% (57%) but platelet parameters had the best overall 
efficiency (81%), FN rate (11%) and FP rate (8%).  
4.2.3 District tier laboratory (Dr Yusuf Dadoo) 
As was seen in the tertiary and regional laboratories, the sensitivity of the parameters was very 
poor (See Table 3.17) when assessed as a single parameter. The specificity was excellent for all 
parameters. Efficiency was >60% for all the parameters, but poorest for the MCV>105 fl and 
WCC <4 x 10^9/L flags (66% and 69% respectively).   
When the parameter flags were assessed per lineage (and not per individual parameter), 
collectively the red cell lineage had the best sensitivity with both white cell and platelet 
parameters achieving a sensitivity of <30%. The specificity and efficiency of all lineages was 
good though, however the FN rates were undesirably high (Table 3.16). 
4.3 Morphology flags 
A direct comparison between the morphology flags from the different laboratory tiers could not 
be done as the analysers used in the three tiers were not the same. Furthermore, the samples 
included were not analysed on more than one analyser, and differences between the morphology 
flags triggered by different analysers in the same sample has thus not been assessed. Nonetheless, 
there were considerable differences in the flags triggered by the analysers from the different tiers, 
even in those flags triggered by all three analysers. Of note, the HCVAR, LS and blast flags were 
the most common flags triggered by the Advia (tertiary tier laboratory) while the Sysmex 
analyser (regional tier laboratory) flagged a higher proportion of IG, ALYMs and PCL. NRBCs 
and PCL were the most commonly triggered flags by the Beckman Coulter (district laboratory) 
analyser.  
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4.3.1 Tertiary tier laboratory (HJH) 
 
The analyser-generated morphology flags were assessed for sensitivity, specificity, efficiency, FN 
and FP rates for both the specific morphology finding for which they were flagged e.g. red cell 
fragments as well as general morphology findings in the lineage specified (i.e. Red cells, white 
cells or platelets). 
Analysis revealed generally low sensitivity but high specificity for both general and specific 
morphology findings (Table 3.5). No morphology flag had sensitivity>50% and most had FN 
rates in excess of 10%. FP rates were generally low. 
4.3.2 Regional tier laboratories (Tambo Memorial/Sebokeng) 
Analysis revealed sensitivity exceeding 50% for the ALYM, IGs and PCL flags in both general 
and specific morphology analysis. Specificity was >80% for all morphology flags and efficiency 
rates were >70%, meaning they may be useful in guiding PBS review. The FN rates for most of 
the morphology flags were good when assessed for the specific finding with the exception of the 
LS flag. In comparison, the FN results for the general lineage morphology was>20% in all but the 
IG and PCL flags (Table 3.10).  
4.3.3 District tier laboratory (Dr Yusuf Dadoo) 
Analysis revealed good sensitivity for specific morphology findings in the flags triggered by the 
Beckman Coulter in this sample population. Sensitivity for the more general morphology was 
good for all flags other than the fragment flag. Specificity was good for the fragment and PCL 
flags but very poor for the NRBC flag. This translated to very good efficiency for the fragment 
and PCL flags for both general and specific morphology but again, poor efficiency of the NRBC 
flag. The FN rates for most of the morphology flags were good when assessed for the specific 
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finding and not as good for general lineage morphology (Table 3.15). This was particularly true 
for the fragment flag’s general morphology. 
Eldanasoury et al from Egypt using the Beckman Coulter LH750 on 800 samples also found the 
NRBC and PCL flags to be two of the most commonly triggered (17).These differences in 
flagging may be related to the slightly different technologies employed by the analysers as well 
the specific settings of each analyser in the laboratory as well as possible differences in pathology 
across the different health tiers. A study assessing morphology flags from laboratories using the 
same analyser but from different health tiers would be of interest. The absence or under-
representation of some morphology flags in each laboratory limited evaluation of these specific 
flags, however, this study was conducted as a cross-sectional analysis of a random sample 
population. Every laboratory that elects to validate these rules would need to ensure adequate 
representation of each morphology flag to complete the validation. 
Kim et al from Korea evaluated the Advia, Sysmex and Beckman Coulter analysers and found 
that over all three analysers the platelet count and IG flags accounted for the largest proportion of 
PBS reviews. The Sysmex analyser had nearly double the cases triggered by IG, ALYM, PCL 
and large platelets when compared with the other analysers. This mirrors the flags noted in this 
study in the laboratory using the Sysmex analyser. The Beckman Coulter had greater number of 
RDW triggers than the other analyser which contrasts the finding of this study where no RDW 
abnormalities were triggered. This is more likely explained by the patient population in the 
respective hospitals than analyser differences. The only comment Kim makes regarding the Advia 
flags is that fewer samples with monocytosis or red cell fragments were triggered (19). 
4.4 Sensitivity, Specificity and Efficiency of the ICGH rules. 
The sensitivity and specificity of the ICGH rules at the HJH laboratory were ~90% and 60% 
respectively with efficiency of ~80%.  When compared to other recent studies performing similar 
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evaluations in the developing world in large academic hospitals, the results attained from the 
tertiary laboratory showed similar results. In this study we show a higher sensitivity and lower 
specificity than Comar et al from Brazil, who had a sensitivity of 77.19% and a specificity of 
67.00%(18). This study was also performed in an academic centre (with oncology) however using 
a much larger representative sample population of 1977 samples. Nonetheless, the efficiency of 
the ICGH rules was substantially poorer than that seen in the South African tertiary laboratory 
(70%). The study done in Thailand by Pratumvinit et al was performed in the largest hospital in 
Thailand with a bed capacity of >2000 beds. This hospital is the referral centre for all hospitals in 
Thailand and would be the equivalent of the central academic hospitals in South Africa. A total of 
2114 samples were assessed in the study but unfortunately sensitivity and specificity were not 
published. The efficiency rates published by this group for the ICGH rules, however, was similar 
to our tertiary laboratory result (83.63%) (24). Eldanasoury et al from Egypt had results similar to 
the Brazilian group and showed a lower sensitivity (82.13%), higher specificity (78.32%) and 
similar efficiency (80.37%) to our results. This study was performed in a large university hospital 
with >3000 beds using 800 samples (17).  The reason for the differences in results is likely due to 
the smaller sample size in this study (divided over three different laboratories) as well as inherent 
population differences. These differences stress the need for each laboratory to validate these 
rules and optimise accordingly.  
A similar pattern was seen in the regional laboratory, where the sensitivity and specificity of the 
ICGH rules were ~94% and ~45% respectively, with efficiency of ~75%.  When comparing to the 
other studies using Sysmex analysers, this study had a greater sensitivity and efficiency but lower 
specificity than Comar et al(18) and Kim et al(sensitivity and specificity 60% and 77% 
respectively) (19) but a lower efficiency than Pratumvinit et al (74.5% vs 83.6%) (24).  
In the district laboratory, the ICGH rules had resulted in a sensitivity of >90% and a specificity of 
37.3%. The efficiency was greater than when the laboratory SOP rules were applied to the same 
43 
 
samples. Overall, the efficiency was the least out of all the laboratories assessed (68.6%) and 
lower than the efficiency rates noted in the literature . This finding appears to reflect a poorer 
performance of the consensus rules in hospitals that serve less ill patients (district hospital) with a 
higher proportion of normal/near-normal counts. This finding suggests that the greatest use of 
ICGH rules is in the central and tertiary laboratories where there are a greater number of 
abnormal samples.  
 
4.5 False Positives and possible rule optimisation 
In the tertiary tier laboratory the FP rate was 15.3%, which is somewhat higher than that reported, 
by Kim et al in their study assessing three different analysers, where the Advia had the lowest FP 
rate (11.3%).  The HCVAR, LS and WCC <4 x 109/L were the flags associated with the highest 
FP rates.  
Of the FP samples which had a LS flag, it was triggered in isolation in 2/3 of samples. This 
suggests that the LS flag may not be a reliable flag to guide manual review of the smear when 
seen in isolation. 
Based on the FP sample analysis, it was determined that excluding the HCVAR flag would 
reduce the review rate by 3.4%, while increasing the FN rate by 1.5%. There was only one 
sample in which the HCVAR flag was triggered and the Hb was <7g/dL. This sample had no 
abnormal morphology and was, in fact, assessed as FP. Therefore, optimising the flag by adding 
the rule HB<7g/dL would not aid in reducing the review rate. 
The only rule modification that could be entertained was excluding smear review in samples with 
a WCC from 2-3.99 x 109/L, which would reduce the review rate by 3.8% without increasing the 
FN rate for clinically significant morphology. This finding is particularly pertinent for the South 
African context considering the lower WCC described in African patients (23), and is further 
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supported by the recommendations of the Francophone group who suggested that a low WCC is 
not a good indication for smear review except if a qualitative flag suggests interference with the 
WCC requiring validation of the WCC result by smear assessment (20). Although excluding the 
LS flag would reduce the review rate by ~3%, while increasing the FN rate by ~1.5%, the 
HCVAR and LS flags could not be excluded as they occasionally detected clinically significant 
morphology when triggered in isolation. Adjustment of the analyser sensitivities of these flags 
may be of benefit in further reducing the FP rate.  
The overall FP rate for the regional tier laboratories was 21.5%, with the most common FP flags 
being the ALYM, IG, PLC and WCC<4 x 109/L flags. These findings are very similar to those of 
Comar et al, who found FP rates of 21.93% and 28.46% using the Sysmex XE-2100D and 
XT2000i analysers respectively in a much larger cohort (n=1977) (18). The main rules producing 
FP results in this study included leucocytes<4 x 109/L, plts <100 x 109/L and unspecified suspect 
flags.  
In our cohort, excluding the ALYM flag would reduce the review rate by 2.5% while increasing 
the FN rate by 1.5% and with a sensitivity of >70%, excluding the IG flag would reduce the 
review rate by 5% while increasing the FN rate by an unacceptable 3%. However, exclusion of 
either of these flags was not considered as both detected clinically significant morphology.   
One could consider reducing the Hb threshold from 7 g/dL to 5 g/dL, however, as this was only 
evaluated in one sample this would require further investigation in a larger cohort. This 
modification in this cohort would reduce the review rate by 2.5% and increase the FN rate by 
0.5%.  
Considering the four of the most triggered flags (i.e. ALYM, PLC, IG and WCC<4), one or more 
were triggered in 91 patients, 65 of which (n=91, 71.4%) were regarded as TP. Excluding all 4 of 
these flags would be likely to increase the FN rate unacceptably. Therefore, the possibility of 
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excluding only the PCL and the WCC2-4 x 109/L flags was evaluated further, as exclusion of 
these flags in isolation did not increase the FN rate. Eighteen samples had only the PCL and/or 
WCC 2-3.99 x 109/L flags triggered, 8 of which were TP. The morphology detected in these 
samples included PCL (in patients with normal platelet counts), large platelets, LS, RF and/or 
TG. Removing both of these flags would reduce the review rate by 9% while increasing the FN 
rate by 4%, however the morphology detected in these FN samples was not considered to be of 
major clinical significance (15).  
Caution would need to be exercised in implementing these modifications with respect to the PCL 
rule, as the detection of platelet clumping in patients with low grade thrombocytopenia (100-
149x109/l) would be of some clinical value. For this reason, modification of this rule should 
perhaps only be considered in conjunction with normal/high platelet counts. Adjustment of the 
analyser sensitivities for the ALYM and IG flags may also be of benefit in further reducing the 
FP rate.  
The district tier laboratory had the highest FP rate (26.4%), with the most common FP rules 
triggered in isolation being the NRBC and WCC<4 x 109/L flags.  These flags never detected 
clinically significant morphology, and disregarding these flags could therefore be considered. The 
NRBC flag was the least reliable in this sample population as ~70% of the time this flag was 
triggered in isolation and resulted in a FP flagging suggesting that this flag triggered in isolation 
may not be a reliable indicator of pathology. NRBCs were triggered in 65 cases. Thirty of these 
were TP with 6 (n=30; 20%) being triggered in isolation. All of the latter had normal/near-normal 
counts and the morphology detected included ALYMs in three patients, large platelets in two 
patients and TG in one patient. Optimisation of this flag including changing the WCC vote-out 
limit or SL cut-off (as discussed in Table 1.1) could reduce the manual review rate by >20%. 
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Together, the WCC<4 flag and the NRBC flag were the only flags triggered in 34 cases. 
Excluding both of these flags would reduce the review rate by 24%while increasing the FN rate 
by 7.9%. None of the morphology missed in the FN samples was clinically critical. 
Unfortunately, as no samples had a WCC <2 x 109/L in this sample population, the value of 
smear review in samples with WCCs in this range has not been assessed.  It may thus be prudent 
to adjust the rule to exclude smear review only in samples with a WCC in the range of 2-3.999/L 
as was proposed in the regional and tertiary laboratories. In comparison with the other Beckman 
Coulter results published, the overall FP rate of the district laboratory was much higher (26.4% 
versus 13.7% (Kim et al(19)) and 10% (Eldanasouryet al (17)). Although these studies were also 
performed in the developing world, they assessed patients in large academic hospitals with 
oncology centres and used larger samples (800 and 1485 respectively). The finding of a higher FP 
rate is likely related to the population studied and health tier differences between this study and 
the other studies published considering the poorer performance of the consensus rules in hospitals 
that serve less ill patients (district hospital) and a higher proportion of normal/near-normal counts. 
4.6 False Negatives 
4.6.1 Tertiary tier laboratory (HJH) 
The FN rate in the tertiary tier laboratory was reduced from 11% to 5.8%. The accepted FN rate 
in the literature stands at 5% (16) and minor adjustments through optimisation of the ICGH rules 
may improve this rate further. 
Laboratory SOP 
Samples which were missed included 14 samples with NRBCs (n=260, 5.4%), eight samples with 
LS (n=260, 3.1%), five samples with ALYM (n=260, 1.9%), four samples with red cell fragments 
(n=260, 1.5%), four samples with sickle cells (n=260, 1.5%), and two samples with blasts 
(n=260, 0.8%). Of the 31 samples assessed as FN by laboratory SOP, six (19.4%) had other 
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parameters which would have triggered a comment suggesting a diff count on the authorised FBC 
report (as per laboratory SOP). These smears would not have been manually assessed at the time 
of presentation.  
ICGH rules 
The most common morphology missed using the ICGH rules were ALYMs in four samples 
(n=260, 1.5%). The ALYMs in all of these samples were noted within a heterogeneous 
population of lymphocytes where the majority had, in fact, normal lymphocyte morphology 
although the numbers of ALYMs were >5 and they did qualify as positive morphology according 
to the ICGH guidelines.  The lymphocytes in all of these samples were favoured to be reactive in 
nature and further workup would not have been suggested for any of these. Of some concern, 
review was also omitted in a single sample with blasts. The latter sample had completely normal 
counts with no flags triggered. On PBS review the blasts accounted for ~3% of white cells and 
were noted in the context of a left shift. Also of note was the presence of 9 NRBCs/100 WBC. 
Neither NRBCs nor blasts were flagged by the analyser in this sample. Considering the pathology 
missed, an overall FN rate of 5.8% is unacceptable.  
In contrast, the Advia results in Kim et al’s study revealed a much higher FN rate of 14.3%. RBC 
morphology and PLT morphology accounted for the clear majority of FN samples. In the study 
by David and Schapkaitz PCL and red cell fragments also had the highest false negative rate of 
the cohort studied at 30.0% and 16.4% respectively (22). 
4.6.2 Regional tier laboratories (Tambo Memorial/Sebokeng) 
In the regional tier laboratory, the FN rate was reduced from 5.0% to an ideal 3.5%, however, this 
was done at the expense of an increased FP rate (17.5% to 21.5%).  
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Laboratory SOP 
Samples which were missed included two with ALYM (n=200, 1.0%) and three samples with LS 
(n=200, 1.5%).Of the two ALYM samples, one had a range of heterogeneous lymphocytes which 
were favoured to be reactive in nature, however, the other sample revealed a greater majority of 
ALYMs some of which were somewhat primitive, and ongoing monitoring of the counts and the 
PBS would have been suggested. The samples with LS included two samples with a mild, likely 
clinically insignificant LS while one sample revealed numerous pseudo-pelgerised neutrophils 
along with left shift and toxic granulation. Although it was considered that this finding may be 
storage-related or artefactual, a repeat sample with ongoing monitoring would have been 
suggested for confirmation. Of the five samples discussed only one had morphology flags 
triggered which would have prompted the reviewer to do PBS review had morphology flags been 
included in the SOP. 
ICGH rules 
The morphology missed in the FN samples was marginally better using the ICGH rules. Samples 
which were missed included two samples with LS (n=200, 1%) and one sample with ALYM 
(n=200, 0.5%). Interestingly, these samples were some of the same ones missed using laboratory 
SOP and the ICGH rules did not miss any samples that were correctly picked up using the 
laboratory SOP. The ALYM sample missed by the ICGH rules was the sample where ongoing 
monitoring would have been advised and the LS samples missed included one clinically less 
significant sample and the one sample with pseudo-pelgerised neutrophils requiring either repeat 
sampling or ongoing monitoring.  
The FN results reported in studies using the same analyser showed a range from 2.2% (24) to 
10.7% (25), and the FN rate reported in this study therefore compares very favourably on 
implementation of the ICGH rules. Keeping this in mind, the optimisation strategy employed in 
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this health tier would be focused on reduction of the number of FP samples in an effort to reduce 
the review rate. 
4.6.3 District tier laboratory (Dr Yusuf Dadoo) 
The biggest reduction in FN rates was seen in the district tier laboratory with a reduction from 
32% to 5%, but this was accompanied by the largest increase in FP rates (6% to 26%).  
Laboratory SOP 
The laboratory SOP rules had an unacceptably high FN rate of 32.1%, the highest of all three 
health tiers. The morphology missed using the laboratory SOP included red cell (RF in 14 
samples (n=140, 10.0%)), white cell (ALYM in 14 samples (n=140, 10.0%) and LS in 10 samples 
(n=140, 7.1%)) and platelet derangements (PCL in 8 samples (n=140, 5.7%)). The majority of 
ALYM samples revealed a heterogeneous range of lymphocytes, however, there were 2 samples 
where the lymphocytes looked somewhat primitive and ongoing monitoring would have been 
advised. Of the samples missed with LS, the majority just made the cut-off of LS as defined in the 
ICGH rules having just one myelocyte. There were 2 samples with more significant LS which 
may have warranted ongoing monitoring. The platelet clumping samples missed using the 
laboratory SOP had platelet counts >100 x 109/L and the PCL was unlikely to have been 
clinically significant in the majority of samples. One sample had a borderline platelet count of 
149 x 10^9/L which would likely have increased to the normal range for age if the platelet 
clumping had been detected.  
ICGH rules 
 Similar morphology was missed using the ICGH rules but in fewer samples with the exception of 
ALYMs and PCL which were only missed using the laboratory SOP. Those missed included four 
samples with LS (n=140, 2.9%), two of which had more significant LS (moderate numbers of left 
shifted forms) and RF in three samples (n=140, 2.1%). Much like the regional laboratory, there 
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were no FN samples triggered using the ICGH rules that were not also FN using the laboratory 
SOP. 
The Beckman Coulter in Kim et al’s study revealed a FN rate with the same value as for the 
Advia in their series (14.3%) which was a lot higher than the current study. Eldanasoury et al 
(also using a Beckman Coulter) reported a FN rate of 9.25%. Both of these studies were 
conducted in a much larger academic hospital with patients that were likely to have a greater 
degree of pathology with fewer normal samples than those patients at Dr Yusuf Dadoo hospital, 
which may account for the lower FN rate.  
4.7 Clinically significant morphology 
Examples of the importance of deciding on clinically significant morphology were found in each 
of the three health tiers assessed. In the tertiary laboratory the HCVAR flag was triggered in 
isolation in 4 instances. Two of these had more clinically significant findings (as defined by Bain) 
(15) (one a leukoerythroblastic reaction (worrying for possible bone marrow infiltration) and the 
other spherocytes (features of haemolysis)), while the other two showed less critical findings 
(ALYMs within a population of heterogeneous lymphocytes in one and target cells with NRBCs 
(4/100 WBC) in the other. Neither of the latter two samples were considered to be of major 
clinical significance although they did qualify as positive smear findings using the ICGH criteria.  
In the regional laboratory the IG flag was triggered in isolation in six TP samples. One of these 
samples had clinically significant morphology of blasts while the others revealed 
reactive/infective changes which were not deemed to be clinically critical.  
Another example from the regional laboratories which introduced the concept of the “non-critical 
FN rate” was noted when looking at the PCL and WCC from 2-3.99 x 109/L. Eighteen samples 
had only the PCL and/or WCC2-3.99 x 109/L flags triggered, eight of which were TP. No critical 
pathology was missed in any of these instances (PCL (in patients with normal platelet counts), 
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large platelets, LS, RF and/or TG). It was found that removing both of these flags would reduce 
the review rate by 9% while increasing the non-critical FN rate by 4%.  
In the district laboratory the NRBC flag was the least reliable in this sample population as ~70% 
of the time this flag was triggered in isolation and resulted in a FP flagging. Thirty TP cases were 
noted with six being triggered in isolation. All of the latter had normal/near-normal counts and 
the morphology detected was not clinically critical (ALYMs in three patients, large platelets in 
two patients and TG in one patient). 
4.8 Laboratory managers’ feedback 
Two laboratories (HJH and Sebokeng) report not having enough staff for the Diff bench to cover 
night shift with subsequent time off or if technologists need a leave of absence. This puts the 
bench and the remainder of the staff under considerable strain. HJH is the only laboratory with 
monospecialist technologists in haematology but the other laboratories do have clinical pathology 
technologists trained and competent in signing out peripheral smear review comments and Diff 
counts.  
The concerns raised by the laboratory managers in reply to the initial questionnaire highlight the 
importance of introducing validated smear review rules which will reduce the manual review rate 
while maintaining an adequate FN rate. Of particular note, the laboratory managers from the 
tertiary and regional laboratories both report a need for possible optimisation of the smear review 
rules.   
4.9 Limitations 
This study has a number of limitations which could be addressed by the individual laboratory 
choosing to perform a similar validation in the future. A limitation which affected all health tiers 
but had the greatest impact on the district laboratory was the representation of samples in the 
randomly selected sample population. In an effort to select a randomly representative sample 
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reflective of the laboratory’s patient profile, certain morphology flags were not triggered in 
enough samples for assessment. In the tertiary and regional laboratories this was the fragment 
flag and in the district laboratory this was LS, IG, Blasts and ALYM flags. Lack of representation 
in these laboratories then did not allow for validation of these flags individually and were not 
triggered in a large enough proportion of the samples for statistically significant optimisation to 
follow. 
For this reason, every laboratory that implements these rules in order to reduce manual smear 
review rates must ensure they use a sample which is not only representative of the samples seen 
in the laboratory but also enough samples for each parameter and morphology flag to have 
acceptable representation for optimisation.  
The tertiary tier laboratory (HJH) had a higher Diff count proportion than what is routinely seen 
in the laboratory. In this study 66% of samples were manually reviewed owing to differential 
count request by the doctor whereas the statistics reported by the laboratory manager over the 
same time period reflect a lower number of differential counts (~10%) of total FBC samples. This 
sample bias did skew the review rate in this study and may not have been a true reflection of 
standard practice at the laboratory.  
4.10 Future recommendations  
When starting this study the main goal was to assess the possibility of reducing the manual smear 
review rate in a laboratory representative of each health tier using the ICGH consensus rules. 
From the data analysed it is evident that implementation of the rules with certain modifications 
and optimisation could aid to reduce the review rate in tertiary tier laboratories where the smear 
workload is at its greatest. As for the regional and district tier laboratories, adoption of a validated 
rule set which makes use of parameter and morphology flags is imperative, not only to prevent 
every smear from being manually assessed but also to ensure an acceptable FN rate and avoid 
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missing clinically significant morphology. Performance of the ICGH rules was poorer in the 
smaller laboratories which reported a greater number of normal/near-normal blood results. In the 
South African context, Joubert et al recorded results which were noted to be very similar to those 
attained using the regional (Sysmex) laboratory SOP with only a slightly better specificity (25). 
As the study by Joubert et al was not an analysis of the ICGH rules but rather of the Sysmex 
analyser and performed in two regional tier laboratories in South Africa, this is an encouraging 
similarity which reveals reproducibility of results.  
Assessment of the data allowed for tier specific as well as a general recommendation to be made 
for each tier:  
4.10.1 Tertiary laboratory (HJH – Advia 2120) 
1) The Diff count in this sample population accounted for 66% of the manual smear 
reviews.  While this percentage is suspected to be greater than that seen in reality, request 
for a Diff count alone should not be in the criteria for smear review.  
2) Reduction of the WCC from 4 x 109/L to 2 x 109/L as a white cell parameter rule for 
smear review is recommended as this modification would reduce the review rate by 3.8% 
without missing critical pathology. This is the only FP flag that could be modified as the 
morphology flags responsible for increasing the FP rate did sometimes pick up critical 
pathology. A consideration could be made to modify the HCVAR rule to prompt review 
only in those samples with a Hb<7 g/dL, however, the full effect of this rule combination 
could not be assessed as it was only noted in one sample.  Adjustment of the analyser 
sensitivities of the HCVAR and LS flags may be of benefit in further reducing the FP 
rate.  
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4.10.2 Regional laboratories (Tambo Memorial and Sebokeng Hospitals – Sysmex 
XT2000i) 
 
1) Modification of the WCC threshold to that of <2 x 109/L as this would reduce the review 
rate without an impact on the clinically significant FN rate.  
2) Modification of the PCL rule is also recommended, however, this rule should only be 
excluded in the presence of normal/increased platelet counts.  
3) Exclusion of the IG and ALYM flags could not be endorsed owing to the morphology 
picked up in the samples where these flags were triggered, however, an argument could be 
made for adjusting the analyser sensitivities to these flags. This went beyond the scope of this 
study.    
4.10.3 District laboratory (Dr Yusuf Dadoo Hospital –Beckman Coulter Act5diff) 
 
1) Exclusion of the NRBC flag would reduce the manual review rate by >20% without 
missing clinically significant pathology. Should this be deemed too extreme for some 
laboratories, adjustment of the analyser’s NRBC flag to detect NRBC>5 would also 
likely still reduce the manual review rate.  
2) PCL flag should be excluded in samples with normal/high platelet count.  
3) The WCC could be modified to WCC<2 x 109/L in order to reduce the manual review 
rate 
4.10.4 General recommendation 
In this study, I provide examples of where the ICGH rules performed well as well as optimisation 
strategies for each laboratory. There is one recommendation of the ICGH consensus which is 
pertinent to all tiers and that is the validation and optimisation of the positive smear criteria as 
stipulated by the ICGH. These rules would need to be validated for the South African setting, 
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considering the concept of clinically significant morphology (15) and the unique pathology 
encountered in our population. A similar suggestion was made by Comar et al(18) in which they 
mention these criteria are international standards and one would need to clarify if these criteria 
require optimisation before validation of the consensus rules could take place.  
5. Conclusion: 
The capabilities of the modern automated analysers are well known and valued but despite the 
massive improvements in technology there remains a need for manual smear review, particularly 
in samples with abnormal results. In South Africa, the higher proportion of abnormal results 
reflects the increased burden of disease brought about by the high HIV prevalence and associated 
TB epidemic. Employing a version of the ICGH rules for smear review that have been optimised 
for these very conditions that takes into account the unique pathology encountered in our 
hospitals, could aid in reducing the review of unnecessary smears while maintaining an adequate 
level of pathology detection. Each laboratory wishing to employ such rules will need to validate 
them for their specific analyser and sample population. 
 
 
 
 
 
 
 
 
 
56 
 
References 
1. Verso ML. FIRST AUSTRALIAN MEDICAL CONGRESS : section of the history of 
medicine. Med Hist. 1962;6(4):396-7. 
 
2. Lehner J  Greve Band Cassens U. Automation in Hematology. Transfusion Medicine and 
Hemotherapy. 2007(34):328-39. 
 
3. Oliver G. The CROONIAN LECTURES: A CONTRIBUTION to the STUDY of the 
BLOOD and the CIRCULATION: Delivered before the Royal College of Physicians of London. 
Br Med J. 1896;1(1852):1548-50. 
 
4. Green R, Wachsmann-Hogiu S. Development, history, and future of automated cell 
counters. Clinics in laboratory medicine. 2015;35(1):1-10. 
 
5. Moldavan A. Photo-Electric Technique for the Counting of Microscopical Cells. Science. 
1934;80(2069):188-9. 
 
6. Coulter WH, inventor. Means for counting particles suspended in a fluid. USA patent 
3781112A. 1953. 
 
7. Coulter WH. High speed automatic blood cell counter and cell size analyser. National 
Electronics conference; 1956; Chicago. 
 
8. Hansen WP, Hoffman RA. Method and apparatus for automated identification and 
enumeration of specified blood cell subclasses. Google Patents; 1981. 
 
9. Dittrich W, Gohde W Inventor; Flow-through chamber for photometers tp measure and 
count particles in a dispersion medium.1968. 
 
10. Ward PC. The CBC at the turn of the millennium: an overview. Clin Chem. 2000;46(8 Pt 
2):1215-20. 
 
11. Groner W, George WV, inventor; Technicon Instruments Corporation (Tarrytown, NY), 
assignee. METHOD AND APPARATUS FOR ANALYSIS OF LEUKOCYTES USING LIGHT 
SCATTERED BY EACH LEUKOCYTE AT ABSORBING AND NON-ABSORBING 
WAVELENGTH. United States1973. 
 
12. Kurec A. Flow cytometry: principles and practices. MLO Med Lab Obs. 2014;46(5):28, 
30-1. 
 
13. Rappaport ES, Helbert B, Beissner RS, Trowbridge A. Automated hematology: where we 
stand. South Med J. 1988;81(3):365-70. 
 
14. Zandecki M, Genevieve F, Gerard J, Godon A. Spurious counts and spurious results on 
haematology analysers: a review. Part II: white blood cells, red blood cells, haemoglobin, red cell 
indices and reticulocytes. Int J Lab Hematol. 2007;29(1):21-41. 
 
15. Bain BJ. Diagnosis from the blood smear. N Engl J Med. 2005;353(5):498-507. 
 
57 
 
16. Barnes PW, McFadden SL, Machin SJ, Simson E. The international consensus group for 
hematology review: suggested criteria for action following automated CBC and WBC differential 
analysis. Laboratory hematology : official publication of the International Society for Laboratory 
Hematology. 2005;11(2):83-90. 
 
17. Eldanasoury AS Boshnak NH, Abd El Monem RE. Validation of criteria for smear 
reviewfollowing automated blood cell analysis in Ain Shams University Laboratory. International 
Journal of Science and Research. 2016;5(3):484-93. 
 
18. Comar SR, Malvezzi M, Pasquini R. Are the review criteria for automated complete 
blood counts of the International Society of Laboratory Hematology suitable for all hematology 
laboratories? Rev Bras Hematol Hemoter. 2014;36(3):219-25. 
 
19. Kim SJ, Kim Y, Shin S, Song J, Choi JR. Comparison study of the rates of manual 
peripheral blood smear review from 3 automated hematology analyzers, Unicel DxH 800, 
ADVIA 2120i, and XE 2100, using international consensus group guidelines. Arch Pathol Lab 
Med. 2012;136(11):1408-13. 
 
20. Genevieve F, Galoisy AC, Mercier-Bataille D, Wagner-Ballon O, Trimoreau F, 
Fenneteau O, et al. Smear microscopy revision: propositions by the GFHC. feuillets de Biologie. 
2014;56(317):1-9. 
 
21. Department of Health. National Health Insurance for South Africa: Towards universal 
health coverage. Version 40.December 2015. Available from https://www.bhfglobal.com/wp-
content/uploads/2015/03/national_health_insurance_white_paper_10Dec2015.pdf 
 
22. David M, Schapkaitz E. Evaluation of morphology flags on the Advia 2120 haematology 
analyser at a Large Academic Hospital. Poster presentation: African Society of Laboratory 
Medicine; Cape Town, South Africa2014. 
 
23. Haddy TB, Rana SR, Castro O. Benign ethnic neutropenia: what is a normal absolute 
neutrophil count? J Lab Clin Med. 1999;133(1):15-22. 
 
24. Pratumvinit B, Wongkrajang P, Reesukumal K, Klinbua C, Niamjoy P. Validation and 
optimization of criteria for manual smear review following automated blood cell analysis in a 
large university hospital. Arch Pathol Lab Med. 2013;137(3):408-14. 
 
25. Joubert J, Weyers, R. Raubenheimer, J. Reducing unnecessary blood smear 
examinations: can sysmex blood cell analysers help? Medical Technology SA. 2014;28(1):6-12. 
 
 
 
 
 
 
58 
 
A. APPENDIX A: Analyser principles and specifications 
Table A.1 Analyser specifications of three analysers assessed in this study 
Specifications Advia 2120 Sysmex XT2000i Beckman Coulter Act5diff 
Tier Tertiary Regional District 
Throughput FBC: 120 Samples/hr FBC/diff: 
120 Samples/hr FBC/diff/retic: 
74 Samples/hr 
80samples/hr (max.) 60 samples/hr 
Database 
storage 
10 000 records 10 000 records  
Parameters FBC Results: WBC, RBC, 
HGB, HCT, MCV, MCH, 
MCHC, CHCM, RDW, HDW, 
CH, CHDW, PLT 
 
Differential Results (absolute 
and %): NEUT, LYMPH, 
MONO, EOS, BASO, LUC 
(Large Unstained Cells)  
 
Platelet Results: PLT, MPV, 
PDW, PCT  
 
 
Flags: 
WBC: Left Shift, Atypical 
Lymph, Blasts, Immature 
Granulocytes, MPO Deficiency  
ANISO, MICRO, MACRO, HC 
VAR, HYPO, HYPER, RBC 
Fragments, RBC Ghosts, NRBC, 
Platelet Clumps, Large Platelet 
 
FBC Results:  
WBC,RBC,HGB,HCT,MCV,
MCH,MCHC, 
PLT(Impedance and 
Fluorescence)  
 
Differential Results 
(absolute and %): 
NEUT, LYMPH, MONO, 
EO,BASO, RDW-SD, RDW-
CV,MPV 
 
Platelet Results: PLT 
 
 
 
 
Flags: 
Immature granulocytes, 
Blasts, Atypical lympho, Left 
shift, NRBC, RBC lyse 
resistance, RBC 
agglutination, Turbidity, 
Fragments, Iron deficiency, 
Platelet clumping 
FBC Results:  
WBC,HGB, HCT, MCV, 
MCH, MCHC, RDW, 
PLT, MPV, PCT,PDW 
 
Differential Results 
(absolute and %): 
NEUT, LYMPH, MONO, 
EO, BA. 
 
Platelet Results: PLT 
 
 
 
 
 
 
Flags: 
Atypical lymphocytes, 
large immature cells, 
schistocytes, left shift, 
blasts, cold agglutinins, 
platelet aggregates, 
NRBCs 
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B. APPENDIX B: Consensus Rules for Review of Automated Full 
Blood count and White cell Differential 
 
Table B.1Consensus rules for review of automated FBC and Diff (16) 
Full blood count parameters 
Rule # Parameter Primary Secondary  Tertiary 4th Action 1 Action 2 Action 3 
1 Neonates First sample    Slide review   
2 WBC, RBC, 
HGB, PLT, 
Retics 
Exceeds Linearity    Dilute sample & 
rerun 
  
3 WBC, PLT Lower than lab 
verified instrument 
linearity 
   Follow lab SOP   
4 WBC, RBC, 
HGB, PLT 
Vote out    Check sample for 
clot 
Rerun 
sample 
If persists, 
perform 
alternate 
counting 
5 WBC <4.0 or >30.0 AND  first 
time 
  Slide review   
6 WBC <4.0 or >30.0 AND Delta 
failed 
AND 
within 3 
days 
 Slide review   
7 PLT <100 or >1000 AND  first 
time 
  Slide review   
8 PLT Any value AND Delta 
failed 
  Slide review   
9 HGB <7g/dl or >2g/dl 
above the upper 
range for age & sex 
 AND first 
time 
  Slide review Verify 
sample 
integrity 
 
10 MCV <75fl or >105 fl AND  first 
time 
Specime
n <24 
hours 
 Slide review   
11 MCV >105 fl AND adult   Slide review for 
macrocytic 
associated 
changes 
Request 
fresh 
sample if 
no 
macrocyti
c changes 
Report 
with 
comment 
if no fresh 
sample 
12 MCV Any value AND delta 
fail 
  Verify sample 
integrity/identity 
  
13 MCHC >2 units above the 
upper limit of 
reference range 
   Check for 
lipaemia/haemoly
sis/RBC 
agglutination/sph
erocytosis 
  
14 MCHC <30 AND 
normal/high 
MCV 
  MCHC can be 
affected by 
technique of 
venepunture. 
  
15 RDW >22 AND first 
time 
  Slide review   
 
60 
 
Differential Count parameters 
Rule # Parameter Primary Secondary  Tertiary 4t
h 
Action 1 Action 2 Acti
on 3 
17 Neut # <1.0 or >20.0 AND first 
time 
  Slide review   
18 Lymph # >5.0 (adult) or 
>7.0 (<12 yrs. old) 
AND first 
time 
  Slide review   
19 Mono # >1.5 (adult) or 
>3.0 (<12 yrs. old) 
AND first 
time 
  Slide review   
20 Eos # >2.0 AND first 
time 
  Slide review   
21 Baso # >0.5 AND first 
time 
  Slide review   
22 NRBC # Any value AND first 
time 
  Slide review   
Reticulocytes 
23 Retic 
absolute # 
>0.100 AND first 
time 
  Slide review   
Suspect flags 
24 Suspect flag 
(except 
ImmG/Band) 
Flag+ AND first time Adult  Slide review   
25 Suspect flag Flag+ AND first time Child  Slide review   
26 WBC 
unreliability flag 
Flag+ Any   Check sample 
integrity and 
rerun sample 
  
27 RBC fragment Flag+ Any   Slide review   
28 Dimorphic RBC Flag+ AND first time   Slide review   
29 Lyse resistant 
RBC 
Flag+ Any   Review WBC 
histogram 
  
30 PLT clumping Any value    Check sample 
for clots 
  
31 PLT flags PLT & MPV flags 
without PLT 
clumps 
   Slide review   
32 Immature 
granulocyte 
Flag+ AND first time   Slide review   
33 Immature 
granulocytes 
Flag+ AND previous 
confirmed 
result 
+ delta 
check fail 
for WBC 
 Slide review   
34 Left shift Flag+    Follow lab SOP   
35 Atypical/variant 
lymphs 
Flag+ AND first time   Slide review   
36 Atypical/variant 
lymphs 
Flag+ AND previous 
confirmed 
result 
+ delta 
check fail 
for WBC 
 Slide review   
37 Blast flag Flag+ AND first time   Slide review   
38 Blast flag Flag+ AND previous 
confirmed 
result 
Delta 
check pass 
or – delta 
for WBC 
 Follow lab SOP   
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Rule 
# 
 
Parameter 
 
Primary 
 
Secondary  
 
Tertiary 
 
4
t
h 
 
Action 1 
 
Action 2 
 
Action 
3 
40 NRBC flag Flag+    Slide review   
41 Retics Abnormal 
pattern 
   Look at 
instrument 
output 
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C. APPENDIX C: HREC Ethics Certificate 
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D. APPENDIX D: Public Hospital Tiers(21) 
Table D.1 Public hospital tiers 
Tier Service Offered 
District hospital Provide generalist medical services including 
Obstetrics and Gynaecology, Paediatrics, General 
surgery and Family Medicine. 
Regional hospital Specialist support in the eight core specialities 
including Obstetrics and Gynaecology, Paediatrics, 
General surgery, Emergency Medicine, 
Orthopaedics, Diagnostic Radiology and 
Anaesthetics. These hospitals offer supervised 
medical training and have capability and resources 
for research.  
Tertiary hospital Strong core of specialists which may be available 
at regional level but with the addition of other 
specialist and sub-specialist services.  
Central hospital Highly specialised services that require unique 
skilled personnel. 
Specialised hospital Specialised psychiatric services. 
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E. APPENDIX E: Questionnaire sent to laboratory managers 
Good day,  
I am working in the Department of Molecular Medicine and Haematology at Charlotte Maxeke 
Johannesburg Academic Hospital. I am collating data from the regional laboratories and would 
really appreciate your assistance in this matter: 
  
1)      Could you send me your volumes for the months January to March for FBCs requested as 
well as those requested as FBC and differential count? 
2)      Would you mind answering these two questions? 
a.       Do you have enough staff on your haematology bench to cover the work? Do you have 
specific technologists allocated to morphology (i.e. are there morphologists employed in your 
lab?) 
b.      Do you receive complaints from clients (i.e. DOH doctors) about TATs? 
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F. APPENDIX F: Data Collection 
  
1. Study number (Hospital + number of sample) 
2. Demographic information including: 
 a. Age 
 b. Gender 
 c. Ward/clinic 
3. FBC alone versus FBC&Diff 
4. Full blood count including: 
 a. White cell count 
 b. Haemoglobin 
 c. MCV 
 d. MCHC 
 e. RDW 
 f. Platelet count 
5. ICGH rule triggered (Yes=1, No=0) 
 a. WCC<4 x 10^9/L 
 b. WCC>30 x 10^9/L 
 c. Hb<7 g/dL 
 d. Hb>2 g/dL more than upper limit of normal 
 e. MCV<75fl 
 f. MCV>105fl 
 g. RDW>22 
 h. Plts<100 x 10^9/L 
 i. Plts>1000 x 10^9/L 
 j. Neuts<1.0 or >20 x 10^9/L 
 k. Lymphs>5.0 x 10^9/L 
 l. Monos>1.5 x 10^9L 
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 m. Eos>2.0 x 10^9/L 
6. Morphology flags triggered (each flag assessed as yes=1, no=0) 
7. Peripheral smear morphology present on smear 
8. Slide to be reviewed with current SOP (Y/N) 
9. Slide to be reviewed using ICGH rules (Y/N) 
10. Positive smear finding as per ICGH guidelines (Y/N) 
11. True positive/True negative/False positive/False negative
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